© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
This channel has partnered with the Brighteon Store and receives a small commission from all sales generated from an affiliate link.
Click the shop now button below to help out this channel.
"A JAMA study published in November of last year suggested that it had enormous efficacy in treating covid. A more rigorous trial was published in JAMA last month. That study included about 1,500 subjects evenly split and randomized to either a placebo or 100 mg of fluvoxamine twice a day for ten days...
The results were so overwhelming that the study was stopped prematurely. It resulted in a 66% reduction in hospitalization and a 91% reduction in death... When you consider this study and the previous study it seems pretty clear to me that fluvoxamine is a no-brainer when you are talking about treating patients with covid."